Your session is about to expire
← Back to Search
Group 2 (Prevena) for Surgery
Study Summary
This trial looks at using a special device to help with healing after spine surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am over 18 years old.I need a plastic surgeon to close my wound after spine surgery.
- Group 1: Group 1 (control)
- Group 2: Group 2 (Prevena)
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants have enrolled in this clinical trial thus far?
"Indeed, clinicaltrials.gov data indicates that this particular trial is actively recruiting subjects as of November 8th 2022. It was first posted on December 1st 2022 and 285 participants are needed to be enrolled from one location."
Is recruitment for this trial still available to participants?
"As recorded on clinicaltrials.gov, the recruitment process for this trial is still ongoing since it was originally posted in December of 2022 and last updated in November later that year."
What potential hazards may arise from Group 2 (Prevena) treatments?
"There is ample evidence to suggest that Group 2 (Prevena) is safe, and the trial has been given a score of 3. This marks it as being in Phase 4; thus approved for use by medical professionals."
Share this study with friends
Copy Link
Messenger